Epilepsy Talk

Vimpat For Uncontrolled Partial-Onset Seizures

July 20, 2010
8 Comments

A recent multi-center study has confirmed earlier study results that 400 mg/day of Lacosamide (Vimpat) provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients.

Posted in Epilepsy, Medication Issues, News
Tags: few adverse effects, Lacosamide, promsing therapy, reduce frequency and severity, seizure freedom, uncontolled partial-onset seizures, Vimpat

Most Recent Posts

Phylis Feiner Johnson

I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.

View Full Profile →

Follow Epilepsy Talk via Email

Join 3,108 other subscribers

Follow Epilepsy Talk on WordPress.com